Bonifacio, M., Binotto, G., Maino, E., Calistri, E., Marin, L., Scaffidi, L., Frison, L., De Marchi, F., Krampera, M., Semenzato, G., Fanin, R., Ambrosetti, A. and Tiribelli, M. (2015) “Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response”, Haematologica. Pavia, Italy, 100(8), pp. e299-e301. doi: 10.3324/haematol.2015.124685.